3/10
01:15 pm
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
2/24
10:19 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at Guggenheim.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at Guggenheim.
2/24
10:19 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at Guggenheim.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at Guggenheim.
2/24
10:08 am
mlys
Rating for MLYS
Low
Report
Rating for MLYS
2/24
10:08 am
mlys
Rating for MLYS
Low
Report
Rating for MLYS
2/13
12:15 pm
mlys
Rating for MLYS
Low
Report
Rating for MLYS
2/13
12:15 pm
mlys
Rating for MLYS
Low
Report
Rating for MLYS
2/13
12:15 pm
mlys
Rating for MLYS
Low
Report
Rating for MLYS
2/13
08:10 am
mlys
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Low
Report
Mineralys Therapeutics, Inc. (NASDAQ: MLYS) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.